Impact of Co-Morbid Immunocompromise in HPV-Associated Oropharyngeal Squamous Cell Carcinoma. Weng ML, Vitkovska T, Hwang SH, Evans LK, et al. Laryngoscope 2026;136:4279-4289.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Weng ML, Vitkovska T, Hwang SH, Evans LK, et al. Impact of Co-Morbid Immunocompromise in HPV-Associated Oropharyngeal Squamous Cell Carcinoma. Laryngoscope 2026;136:4279-4289.
PMID: 42087463